Assignee
ANGIMMUNE LLC
US·1 granted patent·3 pending applications·0 citations·filing 2013–2024
Top patents by PatentIndex Score
4 records- 0170US2025235546A1Treatment of cancer using a combination of immunomodulation and check point inhibitorsANGIMMUNE LLC·Filed 2024·Application pending·0 cites
- 0260US11098120B2Immunomodulation by anti-CD3 immunotoxins to treat cancers bearing or not uniformly bearing surface CD3ANGIMMUNE LLC·Filed 2018·Granted Aug 24, 2021·0 cites·7 claims
- 0354US2019160179A1Treatment of cancer using a combination of immunomodulation and check point inhibitorsANGIMMUNE LLC·Filed 2019·Application pending·0 cites
- 0443US2015166660A1Immunomodulation by anti-cd3 immunotoxins to treat cancers not uniformly bearing surface cd3ANGIMMUNE LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ANGIMMUNE LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →